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We describe the ﬁrst reported case of an IgG4-related autoimmune ﬁbrosclerosing pseudotumour located in the stomach of a
75-year old woman presenting with weight loss and vomiting. A lesion was detected in the gastric body at endoscopy. Subsequent
characterisation by CTwas suggestive of a gastrointestinal stromal tumour. Following laparoscopic resection, the patient recovered
uneventfully. Histological examination of the resected specimen revealed an IgG4-related ﬁbrosclerosing pseudotumour, a novel
location for this histopathological entity.
1.Introduction
IgG4-related autoimmune ﬁbrosclerosing pseudotumour
was ﬁrst reported to be found in various organs of patients
with autoimmune pancreatitis (AIP), a form of chronic
sclerosing pancreatitis associated with an inﬁltration of T
cells and IgG4-expressing plasma cells. There are multiple
recognised clinical manifestations of IgG4 sclerosing dis-
ease including sclerosing cholangitis, cholecystitis, retroperi-
toneal ﬁbrosis, interstitial pneumonia, tubulointerstitial
nephritis-and inﬂammatory pseudotumour [1]. We present
the case of a patient with a gastric midbody mass which was
characterised histologically as an IgG4-related autoimmune
ﬁbrosclerosing pseudotumour.
2.CaseReport
A 75-year-old woman presented to the fast track endoscopy
service with a two-month history of vomiting, weight loss,
and anaemia. She had no previous medical history of
note and was independent. Initial gastroscopy revealed a
large polypoid lesion in the gastric body (Figure 1)w i t h
abnormal appearing mucosa in the fundus, antrum, and
duodenum. Multiple gastric biopsies were taken, which
under microscopy showed markedly hyperplastic mucosa
with evidence of chronic ulceration; there was no evidence
of malignancy. Computerised tomography (CT) revealed
a well-deﬁned homogenous mass measuring 5 × 5.6cm
projecting within the lumen, arising from the medial wall
of the body of the stomach (Figure 2). Two mesenteric
lymph nodes measuring 9mm and 6mm and one enlarged
left gastric lymph node were also identiﬁed. An endoscopic
ultrasound was attempted but failed because the patient was
unable to be intubated.
The patient subsequently went on to have a laparoscopic
resection of the lesion from the posterior aspect of the
lesser curvature. This was performed by making an anterior
gastrotomy and resecting the lesion using a laparoscopic
linear stapler. Following an intraluminal bleed which was
managed conservatively, she made an uneventful recovery
and was discharged home on day 10 postoperatively.
Histological examination of the specimen (Figure 3)
showed interweaving fascicles of spindle cells, set in a ﬁbrous
stromaofabundantdenseeosinophilicmaterialandapromi-
nent inﬂammatory cell inﬁltrate including lymphocytes,
scattered plasma cells, and many eosinophils. There was one
mitosis per ﬁfty high-power ﬁelds. Immunohistochemical
stains were negative for DOG 1, CD117, S100, desmin,
ALK, and cytokeratin. Actin was equivocal and CD34 was
positiveinthespindlecellpopulation.EMAandIgG4stained
the plasma cells, suggesting an IgG4-related autoimmune
ﬁbrosclerosing pseudotumour. There was an average of2 ISRN Gastroenterology
Figure 1: Oesophagogastroduodenoscopy (OGD). The large poly-
poid mass seen in gastric midbody.
Figure 2: Computed tomography scan. Gastric mass arising from
m e d i a lw a l lo fs t o m a c h .
39 IgG4-positive lymphoplasmacytic cells per high-power
ﬁeld. This lesion extended to the resection margin. The
lymph nodes detected on CT which were removed with the
specimen were reactive in nature.
The patient was seen in clinic two weeks later, by which
time she had made a full recovery after surgery. Subsequent
blood tests revealed that her serum IgG4 was within normal
range (1.09); however, levels had not been examined prior to
resection as an IgG4 autoimmune ﬁbrosclerosing pseudotu-
mour had not been suspected.
3. Discussion
IgG4-related autoimmune ﬁbrosclerosing pseudotumours
have been documented in a variety of diﬀerent anatomical
sites including the liver [2], lungs [3], and pituitary gland
[4]. We are the ﬁrst to report its occurrence in the stomach,
a novel site for this pseudotumour subtype. These lesions
were originally documented in patients with autoimmune
pancreatitis(AIP),adiseaseﬁrstproposedbyYoshidain1995
[5]. In this condition levels of serum IgG4 are signiﬁcantly
increased. There is marked inﬁltration of plasma cells and
CD4- or CD8-positive T lymphocytes with ﬁbrosis in the
Figure 3: Histopathological analysis at 40x. Haematoxylin and
eosin stain showing plump spindle cells set in a ﬁbrous stroma with
eosinophilic material and admixed inﬂammatory cells.
Figure 4: Histopathological analysis at 40x. IgG4 immunohisto-
chemistry demonstrating IgG4 positive plasma cells.
pancreas. To meet the histological diagnosis, there should be
10 or more IgG4-positive lymphoplasmacytic cells per high-
power ﬁeld [6]. In addition, extrapancreatic lesions occur in
AIPsuchassclerosingcholangitis,sclerosingsialadenitis,and
retroperitoneal ﬁbrosis which also show inﬁltration of IgG4-
positive plasma cells. These extrapancreatic manifestations
have led recently to some authors proposing the existence
of a new clinicopathological entity, “Hyper-IgG4”or “IgG4-
related sclerosing disease” [7, 8]. They have shown elevation
of IgG4 within the organs aﬀected although the degree of
IgG4stainingistypicallynotdirectlyreﬂectiveofserumIgG4
levels. Indeed in our patient, serum IgG4 levels were normal
weeks after resection of the pseudotumour although levels
could conceivably been elevated prior to surgery.
Histologically, inﬂammatory pseudotumours are charac-
terised by an irregular proliferation of myoﬁbroblasts with a
surroundinginﬂammatorycellinﬁltrate,composedpredom-
inantly of T lymphocytes and plasma cells. The IgG-related
inﬂammatory pseudotumours are characterised by dense
inﬁltration of IgG4-positive plasma cells and lymphocytes
associated with ﬁbrosis. However, the mechanism by which
increased IgG4 levels can induce pseudotumour formation isISRN Gastroenterology 3
unclear, and typically the pseudotumour presents as the sole
systemic manifestation of “Hyper IgG4”disease.
Such IgG4-related inﬂammatory pseudotumours have
been most commonly reported in the lungs with only
occasional reports of extrapulmonary locations. Nine cases
of lung IgG4-related pseudotumours were described by Zen
et al. [3], 8 of which underwent surgical resection but
one was successfully treated with corticosteroids alone. In
another report one case of inﬂammatory pseudotumour of
the left breast presented as a poorly deﬁned 1.6cm mass
which was removed by excision biopsy due to diagnostic
uncertainty [9].
To conclude, we present the ﬁrst case report of a patient
presenting with an IgG4-related pseudotumour within the
stomach lining. There was no evidence of any other organ
involvement in this patient.
This case highlights how such a lesion can masquerade
as another type of tumour, in this case a GIST, and
as such, although rare, ought to be considered as part
of the diﬀerential diagnosis for spindle cell lesions. The
histopathologicalentityofIgG4-autoimmuneﬁbrosclerosing
pseudotumour is becoming recognised more frequently in a
variety of locations, requiring treatment with steroids rather
than surgery.
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